SyntheticMR develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 5-minute scan.

The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI NEURO is CE-marked and FDA 510(k) cleared. For more information, please visit www.syntheticmr.com

Combinostics’ AI-powered cNeuro suite of products helps clinicians make a difference in the lives of patients with neurological disorders. By quantifying brain images and integrating patient data from multiple sources with insights from previous patients, the company’s unique software tools provide radiologists and clinicians the support they need for confident, evidence-based diagnostic and management decisions. The company was founded in 2014 and is headquartered in Tampere, Finland and was acquired by SyntheticMR AB in January 2025. For more information, please visit www.combinostics.com